← Study Library
Animal · 2003 · n=20
Preclinicalcounts toward this tierRole of thymosin beta4 in tumor metastasis and angiogenesis
Cha HJ, Jeong MJ, Kleinman HK · Journal of the National Cancer Institute
Preclinicalcounts toward this tier
Tumours grew to 21.7 mm (95% CI 17.7–25.7) versus 13.3 mm (11.1–15.3) for control, p=0.036; metastatic lung nodules averaged 46.7 (35.0–57.7) versus 10.9 (6.2–15.6), p<0.001, a more than fourfold increase. Cell migration rose 2.3-fold and tumour vessel number 4.4-fold, with no effect on invasion, proliferation or MMP activity.
- Population
- C57BL/6 mice injected with B16-F10 mouse melanoma cells
- Intervention
- Adenoviral thymosin β4 overexpression in the tumour cells
- Comparator
- Empty-vector adenovirus
- Limitations
- Tβ4 was overexpressed continuously inside tumour cells by a virus, which is not the same exposure as circulating peptide in a person without a tumour; a single aggressive melanoma line.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental · key study